Pharmacology: Anesthetics, Anemia Treatments, NMJ Blockers, and Coagulation Modifiers

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/31

flashcard set

Earn XP

Description and Tags

Comprehensive practice flashcards defining key terminology, mechanisms of action, prototypes, and clinical considerations across general and local anesthetics, anti-anemic agents, neuromuscular junction blockers, and coagulation modifiers.

32 Terms

1
New cards

General Anesthesia

The administration of a combination of medications to achieve analgesia (loss of pain sensation), unconsciousness (loss of awareness), amnesia (loss of memory of the procedure), and the blockage of reflexes to prevent involuntary movement and response to injury.

2
New cards

Balanced Anesthesia

An anesthetic technique combining multiple agents—such as preoperative sedatives, anticholinergics, antiemetics, antihistamines, and opioids—each delivering a specific effect to produce hypnosis, analgesia, and muscle relaxation with minimal toxicity.

3
New cards

Stages of General Anesthesia

The four progressive depths of anesthesia: Stage 1 (analgesia/induction), Stage 2 (excitement/delirium with sympathetic stimulation), Stage 3 (surgical anesthesia with skeletal muscle relaxation and regular respirations), and Stage 4 (medullary depression/paralysis with severe CNS depression and respiratory arrest).

<p>The four progressive depths of anesthesia: Stage 1 (analgesia/induction), Stage 2 (excitement/delirium with sympathetic stimulation), Stage 3 (surgical anesthesia with skeletal muscle relaxation and regular respirations), and Stage 4 (medullary depression/paralysis with severe CNS depression and respiratory arrest).</p>
4
New cards

Midazolam

A prototype intravenous benzodiazepine anesthetic that acts primarily at the limbic system and reticular activating system to potentiate gamma-aminobutyric acid (GABA), providing sedation, anxiolysis, and amnesia before and during surgical or diagnostic procedures.

5
New cards

Nitrous Oxide

A potent gas anesthetic supplied in a blue cylinder that depresses the central nervous system to induce rapid anesthesia and analgesia without muscle relaxation; frequently combined with other agents and always administered with oxygen.

6
New cards

Desflurane

A prototype volatile liquid general anesthetic with a rapid onset (1 to 2 minutes) and rapid recovery (15 to 20 minutes) via pulmonary elimination, commonly utilized in outpatient surgeries.

7
New cards

Malignant Hyperthermia

A severe, potentially fatal pharmacogenetic reaction triggered by volatile liquid anesthetics and neuromuscular junction blockers, marked by muscle rigidity, hyperpyrexia, and acidosis; treated with dantrolene.

8
New cards

Bier Block

A technique of intravenous regional local anesthesia where blood is exsanguinated from an extremity using compression tourniquets prior to injecting a local anesthetic into the limb veins to isolate its distribution.

9
New cards

Ester vs. Amide Local Anesthetics

Ester-type local anesthetics (e.g., procaine, tetracaine) contain one "i" in their name and are rapidly hydrolyzed by plasma esterases, whereas amide-type local anesthetics (e.g., lidocaine) contain two "i"s and are metabolized more slowly by the liver.

10
New cards

Lidocaine

A prototype amide local anesthetic that blocks the generation and conduction of action potentials in sensory nerves by reducing sodium permeability; used for infiltration, nerve blocks, spinal anesthesia, and topical surface numbing.

11
New cards

Erythropoiesis

The biological process of erythrocyte formation in the bone marrow, wherein hemocytoblasts differentiate into reticulocytes and mature erythrocytes that circulate for an average lifespan of 120 days.

12
New cards

Erythropoietin Regulatory Loop

A homeostatic physiological mechanism in which decreased arterial oxygen pressure stimulates the kidneys to release erythropoietin, increasing stem cell proliferation and mature red blood cell production to restore tissue oxygen-carrying capacity.

<p>A homeostatic physiological mechanism in which decreased arterial oxygen pressure stimulates the kidneys to release erythropoietin, increasing stem cell proliferation and mature red blood cell production to restore tissue oxygen-carrying capacity.</p>
13
New cards

Megaloblastic Anemia

A macrocytic anemia characterized by large, immature red blood cells, resulting from a deficiency in folic acid or vitamin B12B_{12} needed for DNA synthesis and normal erythrocyte stromal structure.

14
New cards

Epoetin Alfa

A prototype erythropoiesis-stimulating glycoprotein that acts like endogenous erythropoietin to stimulate RBC production; carries a boxed warning for increased risk of death, stroke, and deep vein thrombosis when hemoglobin rises above 11 g/dL11\,\text{g/dL}.

15
New cards

Ferrous Sulfate

An oral iron preparation prototype that elevates serum iron concentration for incorporation into hemoglobin or ferritin stores; indicated for prevention and treatment of iron deficiency anemia.

16
New cards

Chelating Agents

Therapeutic compounds (from the Greek word for "claw") that bind molecules of heavy metals to form a soluble, nontoxic complex excreted by the kidneys, preventing the deactivation of vital cellular enzyme systems.

17
New cards

Deferoxamine Mesylate

An iron-chelating agent administered intramuscularly, subcutaneously, or intravenously to treat acute iron intoxication and chronic transfusional iron overload in transfusion-dependent anemias.

18
New cards

Hydroxocobalamin

An intramuscular vitamin B12B_{12} prototype essential for nucleic acid and protein synthesis, hematopoiesis, and maintenance of the myelin sheath; used to treat vitamin B12B_{12} deficiency and pernicious anemia.

19
New cards

Hydroxyurea

A cytotoxic antineoplastic agent that increases fetal hemoglobin production in bone marrow, thereby diluting abnormal hemoglobin S and reducing painful vaso-occlusive crises in patients with sickle cell anemia.

20
New cards

Neuromuscular Junction (NMJ)

The synaptic contact site between a motor neuron terminal and a skeletal muscle fiber, where acetylcholine is released across the cleft to activate postjunctional cholinergic receptors and provoke muscle contraction.

21
New cards

Sliding Filament Mechanism

The biological process in which myosin cross-bridges repeatedly bind to actin filaments and pull them inward toward the center of the sarcomere, shortening the muscle fiber and producing contraction.

<p>The biological process in which myosin cross-bridges repeatedly bind to actin filaments and pull them inward toward the center of the sarcomere, shortening the muscle fiber and producing contraction.</p>
22
New cards

Nondepolarizing NMJ Blockers

Skeletal muscle relaxants (e.g., rocuronium, vecuronium) that act as competitive antagonists by occupying nicotinic acetylcholine receptor sites, preventing acetylcholine from binding and inhibiting muscle depolarization.

23
New cards

Rocuronium

A prototype nondepolarizing neuromuscular junction blocking agent with an onset of 45 seconds to 3 minutes, utilized to facilitate endotracheal intubation and induce skeletal muscle relaxation during surgery or mechanical ventilation.

24
New cards

Succinylcholine

The prototype depolarizing neuromuscular blocker that binds to acetylcholine receptors causing initial depolarization and fasciculation, followed by prolonged flaccid paralysis; metabolized by liver-produced plasma cholinesterases.

25
New cards

Hyperkalemic Rhabdomyolysis

A life-threatening complication and pediatric boxed warning for succinylcholine, occurring when acute muscle breakdown in children with undiagnosed myopathies releases massive potassium into the circulation, precipitating cardiac arrest.

26
New cards

Hemostasis

The physiological defense sequence that arrests bleeding following vascular damage, consisting of vascular spasm (vasoconstriction), platelet plug formation, blood coagulation, and clot dissolution (fibrinolysis).

27
New cards

Intrinsic vs. Extrinsic Clotting Pathways

The intrinsic pathway is triggered by internal vascular damage involving Hageman factor, whereas the extrinsic pathway is activated by blood escaping into surrounding injured tissues; both merge into the common pathway to form thrombin and fibrin.

28
New cards

Clopidogrel

An oral antiplatelet prototype whose active metabolite selectively inhibits the P2Y12P2Y_{12} ADP receptor on platelets, preventing subsequent activation of the GPIIb/IIIa receptor complex and decreasing platelet aggregation.

29
New cards

Heparin vs. Warfarin

Heparin is a rapid-acting parenteral anticoagulant that inactivates thrombin and factor Xa via the intrinsic pathway (monitored by aPTT; reversed by protamine sulfate), whereas warfarin is an oral anticoagulant that inhibits vitamin K-dependent factor synthesis via the extrinsic pathway (monitored by PT/INR; reversed by vitamin K).

<p>Heparin is a rapid-acting parenteral anticoagulant that inactivates thrombin and factor Xa via the intrinsic pathway (monitored by aPTT; reversed by protamine sulfate), whereas warfarin is an oral anticoagulant that inhibits vitamin K-dependent factor synthesis via the extrinsic pathway (monitored by PT/INR; reversed by vitamin K).</p>
30
New cards

Alteplase

A recombinant tissue plasminogen activator (tPA) and thrombolytic prototype that enzymatically converts plasminogen to plasmin, lysing fibrin clots, fibrinogen, and other plasma proteins in acute MI, PE, and acute ischemic stroke.

31
New cards

Antihemophilic Factor

A prototype intravenous replacement clotting factor (Factor VIII) required for the transformation of prothrombin to thrombin, used to prevent or manage bleeding episodes in patients with classic hemophilia (hemophilia A).

32
New cards

Aminocaproic Acid

A systemic hemostatic prototype that inhibits plasminogen-activating substances and exerts antiplasmin actions to prevent systemic fibrinolysis and clot breakdown in excessive hyperfibrinolytic bleeding.